743 related articles for article (PubMed ID: 8559307)
1. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
3. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
4. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
8. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
9. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
10. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA
Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
13. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
Sanson M; Marineau C; Desmaze C; Lutchman M; Ruttledge M; Baron C; Narod S; Delattre O; Lenoir G; Thomas G
Hum Mol Genet; 1993 Aug; 2(8):1215-20. PubMed ID: 8401504
[TBL] [Abstract][Full Text] [Related]
14. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
15. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
[TBL] [Abstract][Full Text] [Related]
17. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
[TBL] [Abstract][Full Text] [Related]
18. Deletions on chromosome 22 in sporadic meningioma.
Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
[TBL] [Abstract][Full Text] [Related]
19. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bono P; Grammatico B; Grammatico P; Radice P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):638-41. PubMed ID: 8655145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
